Related Experiment Video
Updated: Dec 29, 2025

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
Published on: February 19, 2016
Advances in colon-targeted nano-drug delivery systems: challenges and solutions
Muhammad Naeem1,2, Uzma Azeem Awan1, Fazli Subhan1
1Department of Biological Sciences, National University of Medical Sciences, Rawalpindi, Punjab, Pakistan.
Abstract:
Nano-drug delivery systems (NDDS) for colon-targeted drug delivery are an active area of research on local diseases affecting the colon, such as ulcerative colitis, Crohn's disease, colon cancer, and for the delivery of peptide or protein drugs and vaccinations. In particular, targeted nano-drug delivery to the colon is advantageous for colon-specific diseases because nanoparticles can accumulate in diseased parts, improve the efficacies of therapeutics, and enable localized treatments, which reduces systemic toxicity. However, there are many hurdles, such as burst drug release, enzyme and acidic degradation of drug and carrier in the stomach, pH variations, mucus entrapment, and systemic uptake in the upper small intestine, which could challenge and compromise the successful delivery of NDDS to the colon. With advancements in NDDS, it may be possible to overcome these challenges leading to efficient drug delivery for colon-specific disorders. This review describes a few of the potential colon-specific drug delivery areas and the challenges faced by colon-targeted orally administered delivery systems, and provides an updated summary of recent advances in the development of orally administered NDDS for colon targeting, and the future advances in this research.
Insights
Nano-drug delivery systems (NDDS) offer targeted colon delivery for diseases like ulcerative colitis and colon cancer. Advances in NDDS aim to overcome challenges for efficient, localized treatment with reduced systemic toxicity.
Area of Science:
- Nanomedicine
- Gastroenterology
- Drug Delivery
Background:
- Nano-drug delivery systems (NDDS) are crucial for treating colon-specific diseases like ulcerative colitis, Crohn's disease, and colon cancer.
- Targeted delivery enhances therapeutic efficacy and reduces systemic toxicity by concentrating treatments in diseased colon areas.
- Challenges include premature drug release, degradation in the stomach, pH variations, mucus entrapment, and upper intestinal uptake.
Purpose of the Study:
- To review potential applications of colon-specific drug delivery systems.
- To identify and discuss challenges associated with orally administered colon-targeted delivery systems.
- To summarize recent advancements and future prospects in orally administered NDDS for colon targeting.
Main Methods:
- Literature review of scientific publications on colon-targeted nano-drug delivery.
- Analysis of challenges and recent advancements in NDDS for oral administration.
- Synthesis of information on the development and future of colon-specific drug delivery.
Main Results:
- NDDS show promise for localized treatment of colon diseases, improving drug efficacy and reducing side effects.
- Significant hurdles remain, including physiological barriers in the gastrointestinal tract that can compromise delivery.
- Recent innovations are emerging to address these challenges, paving the way for more effective colon-targeted therapies.
Conclusions:
- Despite challenges, advancements in NDDS offer significant potential for improved colon-specific drug delivery.
- Overcoming barriers like degradation and premature release is key to successful therapeutic outcomes.
- Continued research into NDDS is vital for developing efficient treatments for colon disorders.
More Related Videos
10:16Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
Published on: February 8, 2017
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Related Concept Videos
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Drug Delivery: Enteral Route